These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24080056)

  • 1. Coadministration of 5% glucose solution and dexamethasone and oxaliplatin-related vascular pain grade: a case study.
    Okada Y; Kajiume S; Taniguchi T; Kimoto S; Ogawa Y; Kiba T
    Clin J Oncol Nurs; 2013 Oct; 17(5):554-5. PubMed ID: 24080056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
    Yoshida Y; Hirata K; Matsuoka H; Iwamoto S; Kotaka M; Fujita H; Aisu N; Hoshino S; Kosaka T; Maeda K; Kiyomi F; Yamashita Y
    Drug Des Devel Ther; 2015; 9():6067-73. PubMed ID: 26648694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Search for Factors Related to Vascular Pain Expression upon Administration of Oxaliplatin into a Peripheral Vein].
    Takagi A; Yonemoto N; Aoyama Y; Touma Y; Kajiwara M; Watanabe K; Miyazaki Y; Koinuma M
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):887-9. PubMed ID: 26197757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiology and management of venous pain during intravenous administration of oxaliplatin].
    Matsuyama K; Mishima H; Ueno H; Kajihara K; Morioka A; Morimoto S; Yamauchi K; Honda Y; Komori K; Tsujinaka T
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):411-4. PubMed ID: 21403443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pain with platinum: oxaliplatin and neuropathy.
    Kiernan MC
    Eur J Cancer; 2007 Dec; 43(18):2631-3. PubMed ID: 17977714
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.
    Argyriou AA; Cavaletti G; Briani C; Velasco R; Bruna J; Campagnolo M; Alberti P; Bergamo F; Cortinovis D; Cazzaniga M; Santos C; Papadimitriou K; Kalofonos HP
    Cancer; 2013 Jan; 119(2):438-44. PubMed ID: 22786764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors.
    Shirao K; Matsumura Y; Yamada Y; Muro K; Gotoh M; Boku N; Ohtsu A; Nagashima F; Sano Y; Mutoh M; Tanigawara Y
    Jpn J Clin Oncol; 2006 May; 36(5):295-300. PubMed ID: 16702162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
    Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
    BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the risk factors for allergic reactions induced by the administration of oxaliplatin.
    Yamauchi H; Goto T; Takayoshi K; Sagara K; Uoi M; Kawanabe C; Matsunaga M; Miyoshi T; Uchino K; Misumi N; Nishino T
    Eur J Cancer Care (Engl); 2015; 24(1):111-6. PubMed ID: 24304429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
    Tonini G; Santini D; Vincenzi B; Borzomati D; Dicuonzo G; La Cesa A; Onori N; Coppola R
    J Biol Regul Homeost Agents; 2002; 16(2):105-9. PubMed ID: 12144121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premedication with fast-acting oxycodone hydrochloride hydrate effectively reduced oxaliplatin-induced severe vascular pain.
    Nagao S; Furihata M; Fukagawa K; Furihata T; Matsuhashi Y; Wada T
    J Infect Chemother; 2017 Jul; 23(7):493-497. PubMed ID: 28285948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laryngopharyngeal dysthesia (LPD) in oxaliplatin infusion (OXLP).
    Bahulikar AV; Joshi JN
    J Assoc Physicians India; 2006 Aug; 54():667. PubMed ID: 16941804
    [No Abstract]   [Full Text] [Related]  

  • 15. Extravasations of oxaliplatin.
    Kretzschmar A; Pink D; Thuss-Patience P; Dörken B; Reichert P; Eckert R
    J Clin Oncol; 2003 Nov; 21(21):4068-9. PubMed ID: 14581435
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
    Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
    Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of allergic reactions to oxaliplatin in colorectal cancer patients.
    Suenaga M; Mizunuma N; Shinozaki E; Matsusaka S; Chin K; Muto T; Konishi F; Hatake K
    J Support Oncol; 2008; 6(8):373-8. PubMed ID: 19149322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.
    Grothey A
    Oncology; 2010; 79(5-6):389-99. PubMed ID: 21447970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents.
    Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R
    Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.
    Fiorentini G; Rossi S; Dentico P; Meucci F; Bonechi F; Bernardeschi P; Cantore M; Guadagni S; De Simone M
    Anticancer Res; 2004; 24(3b):2093-6. PubMed ID: 15274406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.